VIVIMEDLAB — Vivimed Labs Share News
0.000.00%
Last trade - 00:00- IN₹504.95m
- IN₹4.40bn
- IN₹699.89m
Brief: Vivimed Labs Ltd Phaninder Nath Resigns As CFO
Brief: Vivimed Labs CFO And CS Receive Notice From CBI
Brief: Vivimed Labs Says Got Notice From Debt Recovery Tribunal Regarding Application Filed By State Bank Of India
Brief: Vivimed Labs Names Ramakanta Tripathy As CFO
Brief: Vivimed Labs Says CEO And CFO Ramesh Krishnamurthy Resigns
Brief: Vivimed Labs Gets Approval To Manufacture & Market Favipiravir Tablet
Brief: Vivimed Labs Says Gets Approvals For 3 Products From Manufacturing Site In Hyderabad
Brief: Vivimed Labs Gets Approval For 2 Products From Uzbekistan Govt
Brief: Vivimed Labs' FDF Facility In Jeedimetla Obtained Ukraine GMP Approval (Renewal)
Brief: Vivimed Labs Says Got Approval For 1 Product From Uzbekistan Government
Brief: Vivimed Labs CEO Ramesh Krishnamurthy Given Additional Charge As CFO
Brief: Vivimed Labs - Got Approvals For 3 Ophthalmic Products From Sterile Ophthalmic Facility
Brief: India's Vivimed Gets Approvals For Ophthalmic, Oral Liquid Suspension Products
Brief: Vivimed Labs Reappoints Santosh Varalwar As MD
Brief: Vivimed Labs Gets Export Order For Supply Of Generic COVID-19 Drug Favipiravir
Appointment Of Chief Executive Officer
Brief: Vivimed Labs Appoints Ramesh Krishnamurthy As CEO
Brief: India's Vivimed Labs Posts Sept Quarter Consol Loss
Brief: Vivimed Labs Says Report On Vivimed Life Sciences' Drug Recall Has No Effect Co's Business